Usvojena mišljenja i prethodna savjetovanja o zahtjevima za autorizaciju
Usvojena mišljenja i prethodna savjetovanja o zahtjevima za autorizaciju
Usvojena mišljenja i prethodna savjetovanja o zahtjevima za autorizaciju
This page provides further information on the applications for authorisation or review reports, which have undergone consultation. The applications for authorisation are in the opinion development phase until the final opinions of the Committees for Risk Assessment and Socio-economic Analysis have been adopted and sent to the European Commission. Its decision-making process can be followed through the comitology register, where further information is published about the REACH Committee's past and upcoming meetings.
On 1 February 2020, the United Kingdom (UK) withdrew from the EU. The transition period provided by the withdrawal agreement ended on 31 December 2020. As of 1 January 2021, an application for an authorisation submitted by a person established in the UK (except Northern Ireland) is no longer valid in the EU, unless that application has been transferred to a legal entity established in the EU or Northern Ireland before the end of the transition period. Therefore, authorisation applications and decisions in so far as these concern persons established in the UK (except Northern Ireland) are no longer considered valid.
Related links
0003-01 | Initial | Bis(2-ethylhexyl) phthalate (DEHP) | 204-211-0 | 117-81-7 | Grupa Azoty Zakłady Azotowe Kędzierzyn S.A. | Formulation of DEHP in compounds, dry-blends and Plastisol formulations | Withdrawn | Details |
0004-01 | Initial | Bis(2-ethylhexyl) phthalate (DEHP) | 204-211-0 | 117-81-7 | DEZA a.s. | Formulation of DEHP in compounds, dry-blends and Plastisol formulations | Withdrawn | Details |
0352-01 | Initial | Bis(2-ethylhexyl) phthalate | 204-211-0 | 117-81-7 | Baxter SA; Baxter Healthcare SA; Gambro Dasco SpA; Baxter (Malta) Trading Co Ltd; Colorite Europe Ltd. (withdrawn) | Formulation of DEHP mixtures for application in immediate packaging of medicines and medical devices | Opinion development | Details |
0011-01 | Initial | Diarsenic trioxide | 215-481-4 | 1327-53-3 | Linxens France SA | Formulation of diarsenic trioxide into a mixture | Commission decided | Details |
0013-01 | Initial | Hexabromocyclododecane (HBCDD), alpha-hexabromocyclododecane, beta-hexabromocyclododecane, gamma-hexabromocyclododecane |
221-695-9 247-148-4 |
3194-55-6 25637-99-4 134237-50-6 134237-51-7 134237-52-8 |
INEOS Styrenics Netherlands BV INEOS Styrenics Ribecourt SAS INEOS Styrenics Wingles SAS Synthos Dwory 7 spółka z ograniczoną odpowiedzialnością spółka komandytowo-akcyjna. Synthos Kralupy a.s. StyroChem Finland Oy Monotez SA RP Compounds GmbH Synbra Technology bv Sunpor Kunststoff GmbH Dunastyr Polystyrene Manufacturing C. Co. Ltd Versalis SpA Unipol Holland bv |
Formulation of flame retarded expanded polystyrene (EPS) to solid unexpanded pellets using hexabromocyclododecane as the flame retardant additive (for onward use in building applications) | Commission decided | Details |
0360-01 | Initial | 2-ethylhexyl 10-ethyl-4,4-dioctyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate | 239-622-4 | 15571-58-1 | Galata Chemicals GmbH; REAGENS SPA | Formulation of liquid mixtures containing DOTE | Opinion development | Details |
0118-01 | Initial | Pentazinc chromate octahydroxide | 256-418-0 | 49663-84-5 |
Boeing Distribution Deutschland GmbH [name of applicant
in the original application: Aviall Services Inc updated due to a notified change of corporate name]; Finalin GmbH |
Formulation of mixture | Commission decided | Details |
0032-01 | Initial | Chromium trioxide | 215-607-8 | 1333-82-0 |
|
Formulation of mixtures | Commission decided | Details |
0045-01 | Initial | Dichromium tris(chromate) | 246-356-2 | 24613-89-6 | Henkel AG & Co. KGaA Henkel Global SupplyChain B.V. | Formulation of Mixtures | Commission decided | Details |
0121-01 | Initial | Pentazinc chromate octahydroxide | 256-418-0 | 49663-84-5 | Indestructible Paint Ltd. – [Decision discontinued as of 01/01/2021] | Formulation of mixtures | Commission decided | Details |